v3.25.4

SEGMENT INFORMATION (Tables)

12 Months Ended

Dec. 31, 2025

Segment Reporting [Abstract]

Schedule of segment revenues and profit

Segment revenues and profits for the years 2025, 2024 and 2023 were as follows:

			Vision Care																		Pharmaceuticals																		Surgical																		Total
(in millions)			2025						2024						2023						2025						2024						2023						2025						2024						2023						2025						2024						2023
Revenues
Product Sales			$	2,914					$	2,731					$	2,535					$	1,277					$	1,206					$	834					$	889					$	837					$	762					$	5,080					$	4,774					$	4,131
Other Revenues			9						8						8						7						3						2						5						6						5						21						17						15
			2,923						2,739						2,543						1,284						1,209						836						894						843						767						5,101						4,791						4,146
Expenses
Cost of goods sold (excluding amortization and impairments of intangible assets)			1,113						1,002						954						397						374						252						535						492						434
Cost of other revenues			1						1						1						4						3						1						—						—						—
Selling, general and administrative			912						882						832						572						543						322						298						265						248
Research and development			48						46						67						53						33						20						43						42						35
Segment Profit			$	849					$	808					$	689					$	258					$	256					$	241					$	18					$	44					$	50					1,125						1,108						980
Corporate																																																									(679)						(614)						(536)
Amortization of intangible assets																																																									(258)						(288)						(240)
Other expense, net																																																									(75)						(44)						(74)
Operating income																																																									113						162						130
Interest income																																																									12						15						15
Interest expense																																																									(421)						(399)						(283)
Loss on extinguishment of debt																																																									(6)						—						—
Foreign exchange and other																																																									(15)						(12)						(28)
Loss before provision for income taxes																																																									$	(317)					$	(234)					$	(166)

Schedule of revenues by segment and product category

Revenues by segment and product category were as follows:

			Vision Care																		Pharmaceuticals																		Surgical																		Total
(in millions)			2025						2024						2023						2025						2024						2023						2025						2024						2023						2025						2024						2023
Pharmaceuticals			$	5					$	4					$	4					$	1,076					$	965					$	614					$	—					$	—					$	—					$	1,081					$	969					$	618
Devices			1,033						963						888						—						—						—						889						837						762						1,922						1,800						1,650
OTC			1,834						1,724						1,611						—						—						—						—						—						—						1,834						1,724						1,611
Branded and Other Generics			42						40						32						201						241						220						—						—						—						243						281						252
Other revenues			9						8						8						7						3						2						5						6						5						21						17						15
			$	2,923					$	2,739					$	2,543					$	1,284					$	1,209					$	836					$	894					$	843					$	767					$	5,101					$	4,791					$	4,146

Schedule of revenue attributed to a geographic region

Revenues are attributed to a geographic region based on the location of the customer for the years 2025, 2024 and 2023 and were as follows:

(in millions)			2025						2024						2023
U.S. and Puerto Rico			$	2,546					$	2,413					$	1,934
China			358						358						344
France			246						227						210
Japan			186						180						187
Germany			164						152						147
Russia			148						120						106
United Kingdom			137						132						121
Canada			135						127						110
Italy			102						91						82
Spain			101						92						85
Mexico			75						75						68
Poland			75						65						51
South Korea			51						47						46
Other			777						712						655
			$	5,101					$	4,791					$	4,146

Schedule of long-lived assets by geographic region

Long-lived assets consisting of property, plant and equipment, net of accumulated depreciation, are attributed to geographic regions based on their physical location as of December 31, 2025 and 2024 and were as follows:

(in millions)			2025						2024
U.S. and Puerto Rico			$	836					$	798
Ireland			544						424
Germany			162						104
Other			220						159
			$	1,762					$	1,485

Schedule of customers that accounted for 10% or more of total revenue

Major customers that accounted for approximately 10% or more of total revenues were as follows:

			2025						2024
McKesson Corporation			10		%				10		%
Cardinal Health, Inc.			10		%				10		%

X

- Definition

Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 280
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 41
-Subparagraph (b)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

+ Details

Name:	us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-40

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 220
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-41

+ Details

Name:	us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration